Spontaneous malignant transformation of conventional giant cell tumor

Skeletal Radiology

Volumn 33, Issue 3, 2004, Pages 169-175

  Grote, H J ^a   Braun, M ^b   Kalinski, T ^c   Pomjanski, N ^a   Back, W ^d   Bleyl, U ^d   Bocking A ^a   Roessner, A ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bone; DNA image cytometry; Giant cell tumor; Malignant transformation; MRI; Prognosis; Radiographs

Indexed keywords

DNA;

ADULT; ANEUPLOIDY; BONE LESION; CANCER GRADING; CASE REPORT; FEMALE; GIANT CELL TUMOR; HISTOPATHOLOGY; HUMAN; ILIAC CREST; IMAGE CYTOMETRY; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT TRANSFORMATION; MEDICAL DOCUMENTATION; MEDICAL LITERATURE; OSTEOSARCOMA; PELVIS RADIOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ADULT; BIOPSY; BONE NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GIANT CELL TUMOR OF BONE; HUMANS; ILIUM; MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1542315639     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-003-0682-5     Document Type: Review

References (38)

1. Hutter RVP, Worcester JN Jr, Francis KC, Foote FW Jr, Stewart FW. Benign and malignant giant cell tumors of bone: a clinicopathological analysis of the natural history of the disease. Cancer 1962; 15:653-690.
2. Dahlin DC, Cupps RE, Johnson EW Jr. Giant-cell tumor: a study of 195 cases. Cancer 1970; 25:1061-1070.
3. Rock MG, Sim FH, Unni KK, et al. Secondary malignant giant cell tumour of bone: clinicopathological assessment of nineteen patients. J Bone Joint Surg Am 1986; 68:1073-1079.
4. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998; 9:893-899.
5. Böcking A. DNA measurements. When and why? In: Wied GL, Bartels PH, Rosenthal DL, Schenk V, eds. Compendium on quality assurance, proficiency testing and workload limitations in clinical cytology. Chicago: Tutorials of Cytology, 1995:170-188.
6. Pomjanski N, Motherby H, Buckstegge B, Knops K, Rohn BL, Böcking A. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis. Anal Quant Cytol Histol 2001; 23:151-159.
7. Haroske G, Baak JPA, Danielsen H, et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathol 2001; 23:89-95.
8. Werner M, Heintz A, Delling G. DNA cytometry of solitary and aneurysmal bone cysts and low malignancy and high malignancy central osteosarcomas. Current significance within the scope of morphologic diagnosis of intraosseous cystic and osteoblastic lesions. Pathologe 1996; 17:44-49.
9. Böcking A, Adler CP, Common HH, Hilgarth M, Granzen B, Auffermann. Algorithm for a DNA-cytometric diagnosis and grading of malignancy. Anal Quant Cytol Histol 1984; 6:1-8.
10. Murphy WR, Ackerman LV. Benign and malignant giant-cell tumors of bone: a clinical-pathological evaluation of thirty-one cases. Cancer 1956; 9:317-339.
11. Sanerkin NG. Malignancy, aggressiveness, and recurrence in giant cell tumor of bone. Cancer 1980; 46:1641-1649.
12. Schajowicz F. Tumors and tumorlike lesions of bone and joints. Berlin Heidelberg New York: Springer, 1981:232-233.
13. Boriani S, Sudanese A, Baldini N, Picci P. Sarcomatous degeneration of giant cell tumours. Ital J Orthop Traumatol 1986; 12:191-199.
14. Venturi R. Osteosarcoma del femore insorto su antico tumore giganto-cellulare. Chir Organi Mov 1986; 71:411-415.
15. Gitelis S, Wang JW, Quast M, Schajowicz F, Templeton A. Recurrence of a giant-cell tumor with malignant transformation to a fibrosarcoma twenty-five years after primary treatment: a case report. J Bone Joint Surg Am 1989; 71:757-761.
16. Mori Y, Tsuchiya H, Karita M, Nonomura A, Nojima T, Tomita K. Malignant transformation of a giant cell tumor 25 years after initial treatment. Clin Orthop 2000; 381:185-191.
17. Bertoni F, Bacchini P, Staals EL. Malignancy in giant cell tumor. Skeletal Radiol 2003; 32:143-146.
18. Mirra JM. Bone tumors. Philadelphia: Lea & Febiger, 1989:993-1020.
19. Sundaram M, Martin AS, Tayob AA. Case report 182. Spontaneous development of malignancy in a surgically treated giant cell tumor of bone. Skeletal Radiol 1982; 7:282-285.
20. Hefti FL, Gächter A, Remagen W, Nidecker A. Recurrent giant-cell tumor with metaplasia and malignant change, not associated with radiotherapy. A case report. J Bone Joint Surg Am 1992; 74:930-934.
21. Ortiz-Cruz EJ, Quinn RH, Fanburg JC, Rosenberg AE, Mankin HJ. Late development of a malignant fibrous histiocytoma at the site of a giant cell tumor. Clin Orthop 1995; 318:199-204.
22. Sakkers RJ, van der Heul RO, Kroon HM, Taminiau AHM, Hogendoorn PCW. Late malignant transformation of a benign giant-cell tumor of bone. A case report. J Bone Joint Surg Am 1997; 79:259-262.
23. Antal I, Sápi Z, Szendrôi M. Die maligne Entartung eines Riesenzell-tumors am distalen Radiusende - Wertigkeit der DNS-Zytophotometrie. Orthopäde 2000; 29:677-683.
24. Marui T, Yamamoto T, Yoshihara H, Kurosaka M, Mizuno K, Akamatsu T. De novo malignant transformation of giant cell tumor of bone. Skeletal Radiol 2001; 30:104-108.
25. Schwartz HS, Allen GA, Chudoba I, Butler MG. Cytogenetic abnormalities in a rare case of giant cell osteogenic sarcoma. Cancer Genet Cytogenet 1992; 58:60-65.
26. Brien EW, Mirra JM, Kessler S, Suen M, Ho JKS, Yang WT. Benign giant cell tumor of bone with osteosarcomatous transformation ("dedifferentiated" primary malignant GCT): report of two cases. Skeletal Radiol 1997; 26:246-255.
27. McGrath PJ. Giant cell tumor of bone: an analysis of 52 cases. J Bone Joint Surg Br 1972; 54:216-229.
28. Zhu XZ, Steiner GC. Malignant giant cell tumor of bone: malignant transformation of a benign giant cell tumor treated by surgery. Bull Hosp Jt Dis Orthop Inst 1990; 50:169-176.
29. Dorfman HD, Czerniak B. Bone tumors. St Louis: Mosby, 1998:552-553.
30. Dorfman HD, Czerniak B. Bone tumors. St Louis: Mosby, 1998:594-598.
31. Radig K, Schneider-Stock R, Mittler U, Neumann HW, Roessner A. Genetic instability in osteoblastic tumors of the skeletal system. Path Res Pract 1998; 194:669-677.
32. Bridge JA, Neff JR, Mouron BJ. Giant cell tumor of bone. Chromosomal analysis of 48 specimens and review of the literature. Cancer Genet Cytogenet 1992; 58:2-13.
33. Schwartz HS, Jenkins RB, Dahl RJ, Dewald GW. Cytogenetic analyses on giant-cell tumors of bone. Clin Orthop 1989; 240:250-260.
34. Sara A, Ayala AG, Ei-Naggar A, Ro YJ, Raymond AK, Murray JA. Giant cell tumor of bone: a clinicopathologic and DNA flow cytometric analysis. Cancer 1990; 66:2186-2190.
35. Wei G, Xiafei R, Chuanhan F. A flow cytometric study on giant cell tumor of bone. Chin Med J 1996; 109:134-137.
36. Antal I, Sápi Z, Szendrôi M. The prognostic significance of DNA cytometry and proliferation index (Ki-67) in giant cell tumors of bone. Int Orthop 1999; 23:315-319.
37. Murata H, Kusuzaki K, Takeshita H, et al. Cytofluorometric DNA ploidy analysis in giant cell tumor of bone: histologic and prognostic value. Cancer Lett 1999; 16:223-229.
38. Sun D, Biesterfeld S, Adler C-P, Böcking A. Prediction of recurrence in giant cell bone tumors by DNA cytometry. Anal Quant Cytol Histol 1992; 14:341-346.